Editor in Chief Dr KK Aggarwal, Padma Shri Awardee Dated:14 February,2020
Why doctors are advocating holistic care for cancer patients during and post treatment?
A study published in Complementary therapies in clinical practice found that 51% of the 20,000 people in the sample study were found to use complementary therapies while undergoing cancer treatment.
By Samara Mahindra
The World Health Organisation estimates that 2.25 million are living with cancer in India and close to 1.1 million new patients are registered every year. Unlike in the west, cancer treatment in India focuses on medication alone, ignoring lifestyle changes that could prevent relapse. This stems from lack of awareness of integrative oncology that looks beyond medication and focuses on non clinical aspects that improve patient outcomes and works alongside conventional medical care. It’s important to note that, unlike alternative therapies, non clinical aspects or complementary therapies are always accompanied with mainstream treatments like surgery, chemotherapy and radiotherapy. ....read more
Correct picture of mortality only if we report and notify clinical cases
New Classification of COVID 19
The same should be the rule: Notify suspect, clinically confirmed and lab-confirmed
COVID-19: New Name and New Classification includes Clinically Diagnosed Cases
CMAAO Update 13th February: Based on WHO guidelines set in 2015 that ensure the name does not refer to a geographical location, an animal, an individual or group of people, while still being pronounceable and related to the disease....read more
You look at people the same way as you are
Honest people regard everybody as honest and dishonest people regard everybody as dishonest. It all depends on the type of people you interact with. If you do not take bribe, nobody will come and offer bribe to you and you will feel everybody is honest. If you take bribe then everybody will come to you to offer bribe and you will feel that everybody in the society is dishonest....read more
Health Sutras By Dr K K Aggarwal
Eat a balanced diet. Include all 7 colors and 6 tastes in your food.
Healthcare News Monitor
Shortages and potential price increases of generic drugs from India loom if the coronavirus outbreak disrupts suppliers of pharmaceutical ingredients in China past April, according to industry experts. An important supplier of generic drugs to the world, Indian companies procure almost 70 percent of the active pharmaceutical ingredients (APIs) for their medicines from China. India’s generic drugmakers say they currently have enough API supplies from China to cover their operations for up to about three months. “We are comfortably placed with eight to 10 weeks of key inventory in place,” said Debabrata Chakravorty, head of global sourcing and supply chain for Lupin Ltd, adding that the company does have some local suppliers for ingredients. Optimism that the worst of the outbreak centered in China’s Hubei province and its capital Wuhan would be over by April took a major hit late on Wednesday. Chinese health officials, using a broader method of confirming coronavirus cases, said they shot up by nearly 15,000 in Hubei with total deaths in China nearing 1,400. The outbreak and severe travel restrictions aimed at containing its spread has taken a toll on the world’s second-largest economy and disrupted international businesses dependant on Chinese supplies. Sun Pharmaceuticals Industries Ltd said it has sufficient inventory of API and raw materials for the short term and has not seen any major disruption in supplies at the moment.
The Economic Times - Kiran Kabtta Somvanshi
Due to its dependence on China for the supply of some basic ingredients and intermediates, the pharma sector in India has been closely watched to assess the impact of corona virus on its supply chain. However, there may not be any immediate threat to the sector as the current quarter performance is unlikely to be impacted on account of the inventory buffer remaining with the companies. On their third quarter earnings call, the managements of several pharma companies — Sun Pharma, Lupin NSE 0.03 % , Cipla NSE -0.76 % and Aurobindo Pharma — while being cautious about the impact of the spread of the virus, have ruled out any immediate impact on their performance. Lack of information about the spread of virus and lack of visibility on supply shipments is resulting in speculative increase in prices of certain bulk drugs, they said. In Sun Pharma’s earnings call last week, Dilip Shanghvi acknowledged the dependence on China. But he also clarified that the geography in which the majority of the pharma manufacturing units are located is physically different from the location of the spread of the virus. According to Shanghvi, the alleged near-80 per cent price increase in some raw materials (that may be almost entirely dependent on China) is not justified and that speculative buying would have raised these prices. Responding to an analyst question on coronavirus during last week’s earnings call, Kamal Sharma, vice-chairman of Lupin, said that “based on the inventories, we don’t see a disruption in this quarter. If the situation gets eased out in the next threefour weeks, we don’t see an issue; and we will be able to manage without any significant disruption at all”. He acknowledged that there is no visibility on shipment of containers — with the country being in a state of lockdown.
Pune Mirror- Vicky Pathare
In a bid to bring private hospitals into the fold of facilities adept to tackle the highly contagious coronavirus (nCoV), Pune Municipal Corporation (PMC) officials on Thursday held a meeting with representatives of these medical facilities and doctors associated with them. The fact that a large section of patients prefer to visit private hospitals for their treatments seems to have prompted the move. Responding to the civic body’s call, some 19 hospitals have volunteered to set up facilities to deal with nCoV cases. During the meeting, PMC officials apprised the hospitals about the treatment protocols to be followed to treat suspected cases or confirmed patients of the virus. A set of checklists and guidelines have been provided to the hospital representatives, informed PMC health officials. Elaborating on the meet, Dr Ramchandra Hankare, PMC’s health chief, said, “A team of experts from the state government and PMC will visit the hospitals from Monday to inspect isolation wards and other facilities. Once they fulfil the needed criteria, they will be notified for handling and treating patients with symptoms of nCoV or diagnosed to have the virus. However, the samples will be sent only to National Institute of Virology (NIV) in Pune.”
Tension prevailed at Bhima Bhoi Medical College and Hospital (BBMCH) here yesterday after a group of relatives of a patient attacked a nurse over alleged medical negligence. The victim nurse has been identied as Pratima Pradhan. As per the report, a patient from Malpada area of Balangir town had been admitted to the BBMCH for treatment yesterday but his condition deteriorated later. At least two attendants of the patient indulged in an argument with Pratima who was on duty at that time over medical negligence. As the argument escalated further the attendant duo thrashed the victim nurse mercilessly. Post the incident, nurses and other staffs of the hospital staged a protest inside its premise demanding security at the workplace. The protest was withdrawn after local police reached the spot and had a dialogue with the staffs. A meeting of the hospital staff has been scheduled for today to decide the future course of action in connection with the attack.